Elucidating the Function of Non catalytic Domains of Collagenases and Aggrecanases

REFERENCES

• Fini M. E., Cook J. R., Mohan R., Brinckerhoff C. E. Regulation of matrix metalloproteinase gene expression. 1998; 299–356
   Google Scholar
• Porter S., Clark I. M., Kevorkian L., Edwards D. R. The ADAMTS metalloproteinases. Biochem. J. 2005; 386: 15–27
   PubMed Web of Science ®Google Scholar
• Woessner J. F. Jr. The matrix metalloproteinase family. In: Matrix Metalloproteinases, Parks, W.C., and Mecham, R. P. (Eds). Academic Press,. 1998; pp. 1–14
   Google Scholar
• Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006; 69: 562–573
   PubMed Web of Science ®Google Scholar
• Parks W. C., Wilson C. L., Lopez-Boado Y. S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 2004; 4: 617–629
   PubMed Web of Science ®Google Scholar
• Overall C. M. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 2002; 22: 51–86
   PubMed Web of Science ®Google Scholar
• Murphy G., Allan J. A., Willenbrock F., Cockett M. I., O’Connell J. P., Docherty A. J. P. The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 1992; 267: 9612–9618
   PubMed Web of Science ®Google Scholar
• Chung L., Shimokawa K., Dinakarpandian D., Grams F., Fields G. B., Nagase H. Identification of the (RWTNNFREY191)-R-183 region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J. Biol. Chem. 2000; 275: 29610–29617
   PubMed Web of Science ®Google Scholar
• Kuno K., Kanada N., Nakashima E., Fujiki F., Ichimura F., Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 1997; 272: 556–562
   PubMed Web of Science ®Google Scholar
• Kuno K., Terashima Y., Matsushima K. ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix. J. Biol. Chem. 1999; 274: 18821–18826
   PubMed Web of Science ®Google Scholar
• Kuno K., Okada Y., Kawashima H., Nakamura H., Miyasaka M., Ohno H., Matsushima K. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett. 2000; 478: 241–245
   PubMed Web of Science ®Google Scholar
• Colige A., Li S. W., Sieron A. L., Nusgens B. V., Prockop D. J., Lapiere C. M. cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. Proc. Natl. Acad. Sci. USA 1997; 94: 2374–2379
   PubMed Web of Science ®Google Scholar
• Fernandes R. J., Hirohata S., Engle J. M., Colige A., Cohn D. H., Eyre D. R., Apte S. S. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J. Biol. Chem. 2001; 276: 31502–31509
   PubMed Web of Science ®Google Scholar
• Colige A., Vandenberghe I., Thiry M., Lambert C. A., Van Beeumen J., Li S. W., Prockop D. J., Lapiere C. M., Nusgens B. V. Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J. Biol. Chem. 2002; 277: 5756–5766
   PubMed Web of Science ®Google Scholar
• Zheng X., Nishio K., Majerus E. M., Sadler J. E. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. J. Biol. Chem. 2003; 278: 30136–30141
   PubMed Web of Science ®Google Scholar
• Liu C. J., Kong W., Ilalov K., Yu S., Xu K., Prazak L., Fajardo M., Sehgal B., Di Cesare P. E. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J. 2006; 20: 988–990
   PubMed Web of Science ®Google Scholar
• Liu C. J., Kong W., Xu K., Luan Y., Ilalov K., Sehgal B., Yu S., Howell R. D., Di Cesare P. E. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J. Biol. Chem. 2006; 281: 15800–15808
   PubMed Web of Science ®Google Scholar
• Sandy J. D., Neame P. J., Boynton R. E., Flannery C. R. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 1991; 266: 8683–8685
   PubMed Web of Science ®Google Scholar
• Glasson S. S., Askew R., Sheppard B., Carito B. A., Blanchet T., Ma H. L., Flannery C. R., Kanki K., Wang E., Peluso D., Yang Z., Majumdar M. K., Morris E. A. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthr. Rheum. 2004; 50: 2547–2558
   PubMed Web of Science ®Google Scholar
• Little C. B., Mittaz L., Belluoccio D., Rogerson F. M., Campbell I. K., Meeker C. T., Bateman J. F., Pritchard M. A., Fosang A. J. ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo. Arthr. Rheum. 2005; 52: 1461–1472
   PubMed Web of Science ®Google Scholar
• Stanton H., Rogerson F. M., East C. J., Golub S. B., Lawlor K. E., Meeker C. T., Little C. B., Last K., Farmer P. J., Campbell I. K., Fourie A. M., Fosang A. J. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature (Lond.) 2005; 434: 648–652
   PubMed Web of Science ®Google Scholar
• Glasson S. S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H. L., Flannery C. R., Peluso D., Kanki K., Yang Z., Majumdar M. K., Morris E. A. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature (Lond.) 2005; 434: 644–648
   PubMed Web of Science ®Google Scholar
• Gross J., Lapiere C. M. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. USA 1962; 48: 1014–1022
   PubMed Web of Science ®Google Scholar
• Li J., Brick P., O’Hare M. C., Skarzynski T., Lloyd L. F., Curry V. A., Clark I. M., Bigg H. F., Hazleman B. L., Cawston T. E. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 1995; 3: 541–549
   PubMed Web of Science ®Google Scholar
• Chung L., Dinakarpandian D., Yoshida N., Lauer-Fields J. L., Fields G. B., Visse R., Nagase H. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J. 2004; 23: 3020–3030
   PubMed Web of Science ®Google Scholar
• Tortorella M. D., Liu R. Q., Burn T., Newton R. C., Arner E. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol. 2002; 21: 499–511
   PubMed Web of Science ®Google Scholar
• Tortorella M., Pratta M., Liu R. Q., Abbaszade I., Ross H., Burn T., Arner E. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J. Biol. Chem. 2000; 275: 25791–25797
   PubMed Web of Science ®Google Scholar
• Kashiwagi M., Enghild J. J., Gendron C., Hughes C., Caterson B., Itoh Y., Nagase H. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J. Biol. Chem. 2004; 279: 10109–10119
   PubMed Web of Science ®Google Scholar
• Gendron C., Kashiwagi M., Lim N. H., Enghild J. J., Thogersen I. B., Hughes C., Caterson B., Nagase H. Proteolytic activities of human ADAMTS-5: comparative Studies with ADAMTS-4. J. Biol. Chem. 2007; 282: 18294–18306
   PubMed Web of Science ®Google Scholar
• Wang P., Tortorella M., England K., Malfait A. M., Thomas G., Arner E. C., Pei D. Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J. Biol. Chem. 2004; 279: 15434–15440
   PubMed Web of Science ®Google Scholar
• Gao G., Plaas A., Thompson V. P., Jin S., Zuo F., Sandy J. D. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J. Biol. Chem. 2004; 279: 10042–10051
   PubMed Web of Science ®Google Scholar
• Milner J. M., Cawston T. E. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr. Drug Targets. Inflamm. Allergy 2005; 4: 363–375
   PubMedGoogle Scholar
• Gomis-Rüth F. X. Structural aspects of the metzincin clan of metalloendopeptidases. Mol. Biotechnol. 2003; 24: 157–202
   PubMed Web of Science ®Google Scholar
• Engel C. K., Pirard B., Schimanski S., Kirsch R., Habermann J., Klingler O., Schlotte V., Weithmann K. U., Wendt K. U. Structural basis for the highly selective inhibition of MMP-13. Chem. Biol. 2005; 12: 181–189
   PubMed Web of Science ®Google Scholar
• Johnson A. R., Pavlovsky A. G., Ortwine D. F., Prior F., Man C. F., Bornemeier D. A., Banotai C. A., Mueller W. T., McConnell P., Yan C., Baragi V., Lesch C., Roark W. H., Wilson M., Datta K., Guzman R., Han H. K., Dyer R. D. Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 (MMP13) that reduces cartilage damage in vivo without joint fibroplasia side effects. J. Biol. Chem., 2007; 282: 27781–27791
   PubMed Web of Science ®Google Scholar